It generally continues unchanged during the switch because it works through an entirely different mechanism (reducing hepatic glucose production) and does not interact with incretin receptors
No medication can specifically target belly fat alone
Book Now No referral needed Most insurance accepted Chesapeake, VA
Kannt A, Madsen AN, Kammermeier C et al (2020) Incretin combination therapy for the treatment of non-alcoholic steatohepatitis
A higher Bcl-2/Bax ratio means cells are more likely to survive
Furthermore, GLP-1 RAs have beneficial effects for reducing the risk of MI or endpoints composed of coronary events (e.g., MACE, cardiovascular mortality), while solid evidence on CCS, vasospastic angina, and MVA is lacking